Truvada News and Research

RSS
Researchers to compare common ARV as a pill and vaginal gel in unique HIV prevention study

Researchers to compare common ARV as a pill and vaginal gel in unique HIV prevention study

Boehringer, Gilead freeze antiretroviral prices for some U.S. agencies

Boehringer, Gilead freeze antiretroviral prices for some U.S. agencies

U.S. PTO's rejection of Gilead's antiretroviral patents might affect applications in India

U.S. PTO's rejection of Gilead's antiretroviral patents might affect applications in India

Merck to register, lower cost of antiretroviral Atripla in developing countries

Merck to register, lower cost of antiretroviral Atripla in developing countries

FDA approves Atripla for the treatment of HIV-1 infection in adults

FDA approves Atripla for the treatment of HIV-1 infection in adults

Approval of fixed-dose combination treatments for HIV-1 infection

Approval of fixed-dose combination treatments for HIV-1 infection

FDA approves two fixed-dose combination treatments for HIV-1 infection

FDA approves two fixed-dose combination treatments for HIV-1 infection